Gregory T. Went,Timothy J. Fultz,Laurence R. Meyerson
申请号：
US13536008
公开号：
US08329752B2
申请日:
2012.06.28
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides compostions for administering memantine to a subject. Memantine in an extended release form containing 22.5 to 30 mg memantine or a pharmaceutically acceptable salt achieves particular pharmacokinetic criteria such as change in plasma concentration of memantine over time and ratio of maximum memantine plasma concentration to mean memantine plasma concentration.
